b'Closing Notes & TimelineDirectoryto national benchmarks, showing improvedDr. Zhijian James Chen reports the near-atomicDevelopment Award recognizing UT SouthwesternDirectorsurvival across stages with rates that are triplestructure of STING. (Shang et al., Nature, 2019) faculty and staff for innovations that advanceJames Brugarolas, M.D., Ph.D.RADIATION ONCOLOGY Scientific Advisory Board J. Falck, Ph.D.national benchmarks for stage 4 patients. patient care. Tu Dan, M.D. Dror Michaelson, M.D., Ph.D. (Chair)Steven McKnight, Ph.D. Dr. Zhijian James Chen, Professor and MemberDr. DeBerardinis receives the 2019 Edith andCo-Leaders Neil Desai, M.D. Massachusetts General Hospital Bruce Posner, Ph.D.The KCP and SPORE award pilot grants rangingof the National Academy of Sciences and anBiostatistics Michael Folkert, M.D., Ph.D. E. Jason Abel, M.D., F.A.C.S.Joseph Ready, Ph.D.from $20,000 to $40,000 to Drs. Artunduaga,HHMI Investigator, receives the BreakthroughPeter ODonnell Award from The Academy ofAlana Christie, M.S. Aurelie Garant, M.D. University of Wisconsin School of MedicineMichael Roth, Ph.D.Conacci-Sorrell, DOrso, Garant, and Patel. Prize in Life Sciences for his discoveries aboutMedicine, Engineering and Science of TexasClinical Research Raquibul Hannan, M.D., Ph.D. and Public Health Uttam Tambar, Ph.D.the innate immune system.(TAMEST). Lucien Nedzi, M.D. Daniel George, M.D.Noelle Williams, Ph.D.Dr. Cadeddu first reports 10-year outcomes ofHans Hammers, M.D., Ph.D. Robert Timmerman, M.D. Duke University Medical Center Yonghao Yu, Ph.D.Education radiofrequency ablation, establishing its role in2020 Roy Elias, M.D. Zabihullah Wardak, M.D. William Oh, M.D.EPIGENETICSprimary tumor management. (Johnson et al., JMount Sinai School of MedicineUrol, 2019)Drs. Courtney, Pedrosa, and Brugarolas report theEpidemiology PEDIATRIC ONCOLOGY Mark Ratain, M.D.Laura Banaszynski, Ph.D.identification of resistance mutations in patientsBijal Balasubramanian, M.B.B.S.,Kenneth Chen, M.D. University of Chicago Medical School Cheng-Ming Chiang, Ph.D.Drs. Timmerman, Hannan, and Brugarolas reportparticipating in the HIF-2 clinical trials, establish- Ph.D. Jonathan Wickiser, M.D. Brian Rini, M.D.William Kraus, Ph.D.innovative use of stereotactic ablative radiother- ing HIF-2 as the first known core dependency ofMetabolism PEDIATRIC UROLOGY Vanderbilt-Ingram Cancer Center Xin Liu, Ph.D.apy to effectively treat oligometastatic diseaseRalph DeBerardinis, M.D., Ph.D. Linda Baker, M.D. Yu Shyr, Ph.D.Ram Mani, Ph.D.and delay need for systemic drug therapy.RCC. (Courtney et al., Clin Cancer Res, 2020) Pathology Micah Jacobs, M.D. Vanderbilt-Ingram Cancer Center Joshua Mendell, M.D., Ph.D.Payal Kapur, M.D. Jose Rizo-Rey, Ph.D.Dr. Kapur reports on a detailed classification ofM. Celeste Simon, Ph.D. (Zhang et al., Int. J Radiat Oncol Biol Phys, 2019) Dr. Zhijian James Chen Bruce Schlomer, M.D. University of Pennsylvania Medical Schoolreceiving Breakthrough Prize. ccRCC based on 33 parameters she identified.Pediatrics Hao Zhu, Ph.D.UT Southwestern is ranked worlds No. 2 aca- ( Steve Jennings/Getty Images) (Cai et al., EBioMedicine, 2020) Kenneth Chen, M.D. RADIOLOGY GENOMICSdemic medical center for published research inRadiation Oncology Alberto Diaz de Leon, M.D. Research Tracks andhealthcare area by Nature Index. The Kidney Cancer Program is named a finalistRaquibul Hannan, M.D., Ph.D. John Leyendecker, M.D. Investigators James Brugarolas, M.D., Ph.D.Dr. Kenneth Chen, Assistant Professor ofRadiology Ivan Pedrosa, M.D., Ph.D. BIOINFORMATICS AND Chao Xing, Ph.D.Drs. Bowman, Sun and Brugarolas receive VPediatrics, joins the Kidney Cancer Programfor the Innovation in Healthcare Award as part ofIvan Pedrosa, M.D., Ph.D. Lori Watumull, M.D. HIF/VHLFoundation Award to develop immunoPET testleadership team. D Magazine and D CEOs inaugural InnovationUrology MACHINE LEARNING Weibo Luo, Ph.D.to predict immunotherapy responsiveness andAwards, recognizing companies, entrepreneurs,Jeffrey Cadeddu, M.D. PATHOLOGY Gaudenz Danuser, Ph.D. Wanpen Vongpatanasin, M.D.report their experience in preclinical models. The Kidney Cancer Program is the recipientand business leaders who are redefining theirLiwei Jia, M.D., Ph.D. Nick Grishin, Ph.D.of the Leaders in Clinical Excellence Programindustries.Payal Kapur, M.D. Lisa Kinch, Ph.D. IMAGING(Vento et al., J Immunother Cancer, 2019) Administration Dinesh Rakheja, M.D. Bo Li, Ph.D. Alberto Diaz de Len, M.D.Director, Research AdministrationRajal Shah, M.D. Venkat Malladi, M.S. David Fetzer, M.D.Rene McKay, Ph.D. CLINICAL GENETICS Jimin Pei, Ph.D. Guiyang Hao, Ph.D.Director of CommunicationsRemington Fenter, M.S., C.G.C. Satwik Rajaram, Ph.D. Kenneth Hoyt, Ph.D.Michelle Parish Amber Gemmell, M.S., C.G.C. Tao Wang, Ph.D. Ananth Madhuranthakam, Ph.D.Senior Administrative AssistantBrian Reys, M.S., C.G.C. Guanghua (Andy) Xiao, Ph.D. Ralph Mason, Ph.D.Deborah Harvey Yang Xie, Ph.D. Ivan Pedrosa, M.D., Ph.D.CLINICAL RESEARCHHe Zhang, Ph.D. Fangyu Peng, M.D., Ph.D.Kidney Cancer Experts COORDINATORS BIOMARKERS Rathan Subramaniam, M.D.Allison Beaver, R.N. Payal Kapur, M.D. Xiankai Sun, Ph.D.ADULT UROLOGY Christina Carrigan, R.N. Dinesh Rakheja, M.D. Jing Wang, Ph.D.Aditya Bagrodia, M.D. Renee Davis, R.N. Takeshi Yokoo, M.D., Ph.D.Jeffrey Cadeddu, M.D. Dendra von Merveldt, R.N. CLINICAL SCIENCESQing Yuan, Ph.D.Jeffrey Gahan, M.D. Jess Ramos, M.H.A. Bijal Balasubramanian, M.B.B.S., Ryan Hutchinson, M.D. Mackenzie Tsang-Lee, R.N. Ph.D. IMMUNOLOGYYair Lotan, M.D. Simon Lee, Ph.D. Esra Akbay, Ph.D.Vitaly Margulis, M.D. Patient Council Sandi Pruitt, Ph.D. Kiyoshi Ariizumi, Ph.D.Ganesh Raj, M.D., Ph.D. Carole Baas, Ph.D. Celette Skinner, Ph.D. Bruce Beutler, M.D.Arthur Sagalowsky, M.D. Larry Carlson Jasmin Tiro, Ph.D. Mingyi Chen, M.D., Ph.D.MEDICAL ONCOLOGY William Marx DEVELOPMENT Zhijian James Chen, Ph.D.Sophia Moschos Thomas Carroll, Ph.D. David Farrar, Ph.D.Waddah Arafat, M.D. Brenda Stinson Kenneth Chen, M.D. Beatriz Fontoura, Ph.D. Isaac Bowman, M.D. Anthony Towler Ondine Cleaver, Ph.D. Yang-Xin Fu, M.D., Ph.D.James Brugarolas, M.D., Ph.D. Jrgen von Hvell Ivan DOrso, Ph.D. Hans Hammers, M.D., Ph.D.Kevin Courtney, M.D., Ph.D. Keri Drake, M.D. Wen Jiang, M.D., Ph.D.Hans Hammers, M.D., Ph.D. Business Advisory Jin Jiang, Ph.D. Nan Yan, Ph.D.Aravind Sanjeevaiah, M.D. Committee Christopher Lu, M.D. METABOLISMMEDICAL ONCOLOGY Andy Geisse Denise Marciano, M.D., Ph.D. Shawn Burgess, Ph.D.(SATELLITE FACILITIES) Bill Huber DRUG DISCOVERY Kevin Courtney, M.D., Ph.D.Suzanne Cole, M.D. Frank Stinson Chuo Chen, Ph.D. Ralph DeBerardinis, M.D., Ph.D.John Lohrey, M.D. David Corey, Ph.D. Sarah Huen, M.D., Ph.D.76 77'